Chang-Yell Shin

Title: Chang-Yell Shin: Innovator in Transdermal Drug Delivery Systems

Introduction

Chang-Yell Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of percutaneous absorption preparations for the treatment of dementia. With a total of 2 patents, his work focuses on enhancing drug delivery methods to improve patient outcomes.

Latest Patents

Chang-Yell Shin's latest patents include innovative formulations aimed at delivering donepezil, a medication used to treat dementia. The first patent describes a percutaneous absorption preparation comprising stabilized donepezil. This preparation includes a support layer, a drug-containing layer, and a release layer. The drug-containing layer features donepezil or its pharmaceutically acceptable salt as the active ingredient, along with stabilizers such as monothioglycerol and potassium thiocyanate. This formulation aims to reduce the formation of donepezil impurities, enhancing its efficacy.

The second patent also focuses on a percutaneous absorption preparation for treating dementia. This formulation contains donepezil as the active component, propylene glycol monocaprylate as a solubilizer, and styrene-isoprene-styrene block copolymer as an adhesive. This preparation is designed to minimize skin irritation while maximizing skin penetration, making it a promising option for patients.

Career Highlights

Throughout his career, Chang-Yell Shin has worked with notable companies in the pharmaceutical industry. He has been associated with Dong-a St Co., Ltd. and Km Transderm Ltd., where he has contributed to the advancement of transdermal drug delivery systems. His expertise in this area has positioned him as a key figure in the development of innovative treatments for dementia.

Collaborations

Chang-Yell Shin has collaborated with esteemed colleagues, including Sun-Woo Jang and Kwang-Ho Cha. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge pharmaceutical technologies.

Conclusion

Chang-Yell Shin's contributions to the field of pharmaceutical technology, particularly in the area of transdermal drug delivery for dementia treatment, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical science and enhancing the quality of life for individuals affected by dementia.